 |
 |

Stroke and Deep Venous Thrombosis Complicating Intravenous Immunoglobulin Infusions
Kenneth A. Katz, MD, MSc;
Chad M. Hivnor, MD;
David E. Geist, BA;
Michael Shapiro, MD;
Michael E. Ming, MD;
Victoria P. Werth, MD
Arch Dermatol. 2003;139:991-993.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
REPORT OF CASES
CASE 1
A 67-year-old woman had a 4-year history of dermatomyositis manifesting as a heliotrope rash, shawl sign, Gottron papules, proximal upper and lower extremity muscle weakness, and dysphagia. The creatine kinase level was 424 U/L (reference range, 2-150 U/L) and the erythrocyte sedimentation rate was 40 mm/h (reference range, 0-25 mm/h). Results of the remainder of the laboratory examination, including globulin levels, were within normal limits. Recent screening colonoscopy, mammography, Papanicolaou smear, and cancer antigen 125 levels showed no evidence of malignancy. She was refractory to a treatment regimen of prednisolone, 60 mg/d; mycophenolate mofetil, 750 mg twice daily; and chloroquine, 250 mg/d. She had not tolerated azathioprine or methotrexate, and trials of quinacrine and hydroxychloroquine had failed. She had chronic hypertension, which was controlled with ramipril, . . . [Full Text of this Article] CASE 2
THERAPEUTIC CHALLENGE
COMMENT
University of Pennsylvania Medical Center, Philadelphia (Drs Katz, Hivnor, Shapiro, Ming, and Werth), and Yale University School of Medicine New Haven, Conn (Mr Geist)
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Frequency of Adverse Events Associated with Intravenous Immunoglobulin Therapy in Patients with Pemphigus or Pemphigoid
Gurcan and Ahmed
The Annals of Pharmacotherapy 2007;41:1604-1610.
ABSTRACT
| FULL TEXT
Acute stroke with high-dose intravenous immune globulin
White and Leonard
Am J Health Syst Pharm 2007;64:1611-1614.
ABSTRACT
| FULL TEXT
Review: intravenous immunoglobulin therapy and thromboembolic complications
Katz and Shoenfeld
Lupus 2005;14:802-808.
ABSTRACT
Letter to the Editor
McCabe et al.
Lupus 2005;14:409-410.
|